MedRx Co., Ltd

4586.T
Drug Manufacturers - Specialty & Generic
2026/08/21 Updated
Market Cap: $27.1M (¥4.3B)
Stock Price: $0.41 (¥65)
Exchange Rate: 1 USD = ¥158.98

Notice of Large-Scale Exercise of the 35th Stock Acquisition Rights Issued via Third-Party Allotment (with Exercise Price Adjustment Provisions)

Regarding the 1,522,200 shares issued since the beginning of the month, 15,222 stock options were exercised (10.30% of the total issued 147,820). As of now, unexercised options amount to 64,173 (6,417,300 shares). This notice discloses the specific exercise dates and share transfers from August 3 to 14.

Importance:
Page Updated: August 14, 2026
IR Disclosure Date: August 14, 2026

Key Figures

  • Allocated shares: 1,522,200 shares
  • Number of stock options exercised: 15,222
  • Total issued: 147,820
  • Unexercised stock options: 64,173 (6,417,300 shares)

AI要約

Section Header

This notice concerns the large-scale exercise of the 35th stock acquisition rights issued via third-party allotment. The number of allocated shares since the beginning of the month is 1,522,200 shares, with 15,222 rights exercised, accounting for 10.30% of the total issued rights. As of now, unexercised rights total 64,173 (6,417,300 shares), and this document discloses the allocation and exercise status for exercise dates August 3, 4, 5, 6, and 14. The number of issued shares at the end of the preceding month for the target month is 66,207,600 shares, and the number of treasury shares is 2.

Section 2 header

A detailed breakdown by exercise date shows that shares were transferred on August 3 (64 shares), August 4 (62 shares), August 5 (2,149 shares), August 6 (1,988 shares), and August 14 (2,049 shares). For more details on this large-scale exercise, please refer to the notice published on May 20, 2026. Investors should monitor the progress of stock option exercises and the potential dilutive impact on shares.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Medix Co., Ltd.

Company overview · Stock price · Financial data · All IR

View company page →